Stay updated with breaking news from Mark Douglas Smith. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $18.15-$19.35 for the period, compared to the consensus estimate of $19.94. The company issued revenue guidance of $4.0-$4.2 billion, compared to the consensus revenue estimate of $4.08 billion. Jazz Pharmaceuticals also updated […]
Aristotle Capital Management LLC purchased a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 175,757 shares of the specialty pharmaceutical company’s stock, valued at approximately $22,748,000. Aristotle Capital […]
Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) had its target price cut by JPMorgan Chase & Co. from $180.00 to $170.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the specialty pharmaceutical company’s stock. JPMorgan Chase & Co.‘s target price indicates a potential upside […]
PNC Financial Services Group Inc. cut its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 36.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,807 shares of the specialty pharmaceutical company’s stock after selling 2,737 shares during the quarter. PNC […]
Rhenman & Partners Asset Management AB decreased its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 0.9% in the 3rd quarter, HoldingsChannel reports. The firm owned 143,634 shares of the specialty pharmaceutical company’s stock after selling 1,366 shares during the quarter. Jazz Pharmaceuticals makes up 2.0% of Rhenman & Partners Asset Management AB’s […]